ARTICLE | Clinical News
ABLC: Began two Phase III trials
July 5, 1994 7:00 AM UTC
The Liposome Co. Inc. (LIPO), Princeton, N.J. Product: ABLC amphotericin B lipid complex Indication: Life-threatening fungal infection in cancer and bone marrow transplants Status: Began two Phase III...